236 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Observational Study of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome
Condition: Interstitial Cystitis
Intervention:
22 Not yet recruiting Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
Conditions: Bladder Exstrophy;   Urinary Incontinence
Intervention: Drug: MDC
23 Recruiting Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Other: Observation
24 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
25 Recruiting Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
26 Recruiting Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
Conditions: Vesicoureteral Reflux;   Renal Hypodysplasia, Nonsyndromic, 1;   Chronic Kidney Disease
Interventions: Drug: nitrofurantoin;   Other: No prophylaxis;   Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Cefixime
27 Recruiting Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
Condition: Overactive Bladder Syndrome
Intervention: Drug: Solifenacin
28 Not yet recruiting Propofol and Sevoflurane for Catheter-Related Bladder Discomfort
Conditions: Catheter Site Discomfort;   Complications;   Anesthesia;   Urinary Bladder Neoplasms
Interventions: Drug: Propofol;   Drug: Sevoflurane
29 Unknown  Female Chronic Pelvic Pain
Conditions: Pelvic Pain;   Abdominal Pain;   Painful Bladder Syndrome;   Interstitial Cystitis;   Irritable Bowel Syndrome
Intervention: Other: Chronic pelvic pain
30 Unknown  Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: chemoprevention
31 Recruiting Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
Conditions: Bladder Cancer;   Urothelial Carcinoma
Interventions: Drug: OGX-427;   Drug: Docetaxel
32 Recruiting 3 Tesla MRI in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: Specimen Ultra-High field MRI;   Drug: chemotherapy;   Procedure: Cystectomy and Lymphadenectomy
33 Unknown  A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
Condition: Overactive Bladder Associated With HTLV-1
Interventions: Drug: Propantheline Bromide;   Drug: Placebo
34 Recruiting Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Drug: Oxytocin;   Other: Saline as a nasal spray
35 Recruiting MIrabegron With oveRACtive bLadder Symptoms in mEn
Condition: Overactive Bladder
Interventions: Drug: mirabegron;   Drug: placebo
36 Recruiting Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
Condition: Carcinoma of Urinary Bladder, Superficial
Intervention: Drug: Epirubicin
37 Recruiting Specified Drug Use-results Survey of Betanis Tablets
Condition: Overactive Bladder
Intervention: Drug: Betanis
38 Unknown  Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
Condition: Overactive Bladder
Intervention: Drug: DETRUSITOL
39 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
40 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years